Health Care

EXCLUSIVE: UnitedHealth Gets Dumped, Why This Asset Manager Says Insurer Is No Longer A Safe Bet

EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results

Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny

EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results

Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

UnitedHealth CEO, Other Insiders Buy Millions In Stock As It Sinks Over 23% In A Week: Move Gets 'Mixed' Reaction

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

UnitedHealth CEO, Other Insiders Buy Millions In Stock As It Sinks Over 23% In A Week: Move Gets 'Mixed' Reaction

Rocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says Analyst

Andreas Halvorsen Bets On A Healthy Comeback For UnitedHealth

Health Care Recent News

A DeepSeek Moment For Anti-Ageing? Eastenova's XH301 Outshines Hyaluronic Acid Product In Clinical Trial

A treatment to smooth out smile lines was more effective than imported hyaluronic acid products in a clinical trial.

Oracle, Cleveland Clinic, G42 Unite To Launch AI-Powered Healthcare Platform

Oracle teams up with Cleveland Clinic and G42 to launch an AI-driven healthcare platform aimed at cutting costs and improving global care.

Jim Cramer Reacts As UnitedHealth Denies Report On Criminal Probe—'If Convicted of Criminal Medicare Fraud…'

Jim Cramer weighed in on the deepening crisis at one of America's largest health insurers, which has lately found itself under intense scrutiny by the public, regulators, and the media.

Doximity Stock Dives On Q4 Earnings As Guidance Comes In Below Estimates

Doximity reports fiscal fourth-quarter financial results after the market close on Thursday.

Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact

Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential deal value above $1.3 billion.

Merck Data Shows Positive Outcomes For Ovarian Cancer Patients Treated With Keytruda

Merck's Phase 3 trial of Keytruda plus chemo met progression-free survival and overall survival goals in platinum-resistant ovarian cancer, including patients with PD-L1–positive tumors.

Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo

Immutep's efti combo with Keytruda and chemo shows a 60.8% response rate in lung cancer trial, with strong efficacy across PD-L1 expression levels.

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space

Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.

What's Going On With Intuitive Surgical Stock On Thursday?

Intuitive Surgical Inc. (NASDAQ: ISRG) announces Dave Rosa as next CEO, effective July 1, 2025. Long-serving CEO Gary Guthart to become executive chair.

Why Is Biohaven Stock Falling On Thursday?

Biohaven secures $250 million from Oberland Capital, with total cash reaching $518 million to support troriluzole launch and operations.

Why Is UnitedHealth Stock Trading Lower On Thursday?

UnitedHealth faces DOJ scrutiny and analyst downgrades after reports of a criminal Medicare fraud probe and executive leadership shakeups.

Palantir Soars 500% In A Year While UnitedHealth Tanks 40% — Tech Leaves Healthcare In The Dust

Bernie Sanders Calls Trump's 'Big Beautiful Bill' A 'Death Sentence,' Says It Delivers $235 Billion Tax Break To Top 0.2%—While 99.8% Of Americans Get Nothing

Sanders accused Republicans of pushing through a disastrous budget bill that benefits the wealthy and harms everyday Americans, citing data on wealth inequality and cuts to programs like Medicaid. He called out the bill's corporate tax breaks and criticized the increase in defense spending.